Status:
COMPLETED
Morphine Added to Ropivacaine for FICB for Postoperative Analgesia
Lead Sponsor:
B.P. Koirala Institute of Health Sciences
Conditions:
Postoperative Pain
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
prospective, randomized double blinded study to investigate the effects of morphine as an adjuvant to ropivacaine on FICB
Eligibility Criteria
Inclusion
- All patients undergoing elective femur surgery under spinal anaesthesia
- Age group (18-65 years)
- ASA physical status I and II
Exclusion
- • Not willing to participate in the study
- Other painful co-morbidities (neuropathies)
- Allergy or any contraindication to study medication
- Psychiatric disorder
- Coagulopathy
- Infection at the site of the block
- Use of other modes of anaesthesia or analgesia besides spinal anaesthesia.
Key Trial Info
Start Date :
April 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2017
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT03875274
Start Date
April 1 2017
End Date
December 31 2017
Last Update
March 24 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
BPKIHS
Dharān, Sunsari, Nepal, 977